Antimicrobial Drugs and Community-acquired Methicillin-Resistant Staphylococcus aureus, United Kingdom
Verena Schneider-Lindner*†, J. A. Delaney*†, Sandra Dial†‡, Andre Dascal‡, and Samy Suissa*†
Author affiliations: *McGill University Health Center, Montreal, Quebec, Canada; †Royal Victoria Hospital, Montreal, Quebec, Canada; ‡Sir Mortimer B. Davis–Jewish General Hospital, Montreal, Quebec, Canada;
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.